These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 239124)

  • 1. The influence of mucin on the bioavailability of tetracycline.
    Kellaway IW; Marriot C
    J Pharm Pharmacol; 1975 Apr; 27(4):281-3. PubMed ID: 239124
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Effect of mucin on the bioavailability of tetracycline from the gastro-intestinal tract: in vivo, in vitro correlations.
    Barry BW; Braybrooks MP
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():64P-65P. PubMed ID: 4156744
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of mucin on the bioavailability of tetracycline from the gastrointestinal tract; in vivo, in vitro correlations.
    Braybrooks MP; Barry BW; Abbs ET
    J Pharm Pharmacol; 1975 Jul; 27(7):508-15. PubMed ID: 239156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of tetracycline hydrochloride in mucin solutions.
    Kearney P; Marriott C
    Adv Exp Med Biol; 1982; 144():105-8. PubMed ID: 6177201
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic].
    Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR
    Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Properties of tetracycline hydrochloride tablets and their bioavailability].
    Zak AF; Batuashvili TA; Loseva GI; Shatrova VM; Ermolova OB
    Antibiotiki; 1980 Mar; 25(3):179-84. PubMed ID: 7362222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
    Zak AF; Ermolova OB
    Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The bioavailability of tetracycline tablets manufactured by pharmaceutical factories in China (author's transl)].
    Li T; Meng JX; Liu DY; Zhu SF; Lu SZ; Gao XY; Shen LL; Yang WS
    Yao Xue Xue Bao; 1981 Nov; 16(11):842-8. PubMed ID: 7342680
    [No Abstract]   [Full Text] [Related]  

  • 9. Rheological evaluation of hog gastric mucin as a model mucus system.
    Marriott C; Kellaway IW
    J Pharm Sci; 1976 Jun; 65(6):828-32. PubMed ID: 932966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cimetidine on the absorption of orally administered tetracycline.
    Fisher P; House F; Inns P; Morrison PJ; Rogers HJ; Bradbrook ID
    Br J Clin Pharmacol; 1980 Feb; 9(2):153-8. PubMed ID: 7356903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability, pharmacokinetics, and plasma concentration of tetracycline hydrochloride fed to swine.
    Kniffen TS; Bane DP; Hall WF; Koritz GD; Bevill RF
    Am J Vet Res; 1989 Apr; 50(4):518-21. PubMed ID: 2712418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality and stability of tetracycline tablets].
    Nesterova LIa; Grakovskaia LK; Shadyro LL; Okhotnikova VF
    Antibiotiki; 1980 Nov; 25(11):828-31. PubMed ID: 7447399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and optimization of tablets containing a self-nano-emulsifying drug delivery system loaded with rosuvastatin.
    Salem HF; Kharshoum RM; Halawa AKA; Naguib DM
    J Liposome Res; 2018 Jun; 28(2):149-160. PubMed ID: 28287014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Influence of a mucin model system upon the bioavailability of phenylbutazone and warfarin sodium from the small intestine.
    Barry BW; Braybrooks MP
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():74P. PubMed ID: 2751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study)].
    Grakovskaia LK; Nesterova LIa; Okhotnikova VF; Zak AF; Ermolova OB
    Antibiotiki; 1978 Mar; 23(3):215-9. PubMed ID: 637528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and in vitro release studies of pegylated mucin based matrix tablets.
    Eraga SO; Arhewoh MI; Iwuagwu MA; Ukponahiusi OE
    Pak J Pharm Sci; 2015 Jan; 28(1):113-8. PubMed ID: 25553689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of adjuvants on the pharmaceutical and biological availability of chlorpromazine hydrochloride].
    Voigt R; Thomas G
    Pharmazie; 1983 Nov; 38(11):736-9. PubMed ID: 6669593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of animal mucins on lysozyme activity in solution and on hydroxyapatite surfaces.
    Park WK; Chung JW; Kim YK; Chung SC; Kho HS
    Arch Oral Biol; 2006 Oct; 51(10):861-9. PubMed ID: 16716246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the tetracycline base crystallization conditions on the properties of the powders and drug forms obtained. Relationship between the dispersity of the tetracycline powder and the biological availability in capsules].
    Lin'kov GI; Okhotnikova VF; Koroleva VG; Nabokov VS; Zhuskovskaia SA
    Antibiotiki; 1978 Feb; 23(2):174-8. PubMed ID: 629528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.